Zobrazeno 1 - 10
of 318
pro vyhledávání: '"Keen B"'
Publikováno v:
Patient Preference and Adherence, Vol Volume 18, Pp 435-454 (2024)
Simon Fifer,1 Brittany Keen,1 Anna Porter2 1Community and Patient Preference Research (CaPPRe), Sydney, NSW, Australia; 2Novo Nordisk, Sydney, NSW, AustraliaCorrespondence: Brittany Keen, Community and Patient Preference Research (CaPPRe), Level 20,
Externí odkaz:
https://doaj.org/article/55f3d8c2ab3d41cfb29e55ab0dacccd3
Publikováno v:
Patient Preference and Adherence, Vol Volume 16, Pp 1687-1701 (2022)
Simon Fifer,1 Brittany Keen,1 Richard Newton,2 Andrea Puig,3 Marija McGeachie4 1Community and Patient Preference Research, Sydney, NSW, Australia; 2Monash University, Melbourne, VIC, Australia; 3Real World Evidence Department, Janssen-Cilag Australia
Externí odkaz:
https://doaj.org/article/e74568387cc4459e92e27b5abe4e0014
Publikováno v:
Biomass Conversion & Biorefinery; Sep2024, Vol. 14 Issue 18, p22137-22150, 14p
Publikováno v:
In Bioresource Technology September 2021 335
Publikováno v:
Biomass Conversion and Biorefinery; September 2024, Vol. 14 Issue: 18 p22137-22150, 14p
Publikováno v:
In Tribology International November 2020 151
Publikováno v:
In Bioresource Technology Reports December 2018 4:114-122
Publikováno v:
Journal of Chromatography B. 1220:123652
The use of catechol-O-methyltransferase inhibitors may mask doping agents, primarily levodopa, administered to racehorses and prolong the stimulating effects of dopaminergic compounds such as dopamine. It is known that 3-methoxytyramine is a metaboli
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::81ecfc4e31ec19604167988956a6f677
https://doi.org/10.1016/j.jchromb.2023.123652
https://doi.org/10.1016/j.jchromb.2023.123652
Metabolomics is a multidisciplinary field providing workflows for complementary approaches to conventional analytical determinations. It allows for the study of metabolically related groups of compounds or even the study of novel pathways within the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______363::ff1f090d5f19b2f7601c4bb081aa6935
https://hdl.handle.net/10453/165962
https://hdl.handle.net/10453/165962
Publikováno v:
Toxicologie Analytique et Clinique. 34:S58
Aim Identify potential biomarkers that are indicative of doping in equine plasma through statistical analysis of metabolomics data. Introduction The purpose of metabolomics is to detect endogenous changes in molecular entities, such as metabolites an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7829b5037493442dd397c1843ae2a82a
https://doi.org/10.1016/j.toxac.2022.06.072
https://doi.org/10.1016/j.toxac.2022.06.072